10-K Decoder · All companies

Mirum Pharmaceuticals, Inc.

MIRM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$521M$337M+54.7%
Operating income−$22.1M−$87.6M+74.7%
Net income−$23.4M−$87.9M+73.4%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$186M$133M+39.6%
Operating income−$59.7M$2.60M
Net income−$40.8M$2.90M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Mirum Pharmaceuticals's revenue in FY2025?
$521M in FY2025 (Fiscal year ended Dec 31, 2025), +54.7% vs $337M a year earlier, per its 10-K filed Feb 2026.
Was Mirum Pharmaceuticals profitable in FY2025?
No: net income was −$23.4M and operating income −$22.1M in FY2025.
What was Mirum Pharmaceuticals's revenue in Q3 2026?
$186M (+39.6% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.